Search results
23 lut 2023 · Pancreatic cancer usually results in poor survival with limited options for treatment, as most affected individuals present with advanced disease. Early detection of preinvasive pancreatic neoplasia and identifying molecular therapeutic targets provide opportunities for extending survival.
17 sty 2024 · Five-Year Survival Rate for Pancreatic Cancer Increased to 13% Signaling More Progress and More Hope for Patients. by Charaighn Sesock — Jan 17, 2024. Despite advances in pancreatic cancer the disease is on track to become the second-leading cause of cancer-related deaths before 2030.
10 paź 2024 · In 2023, an estimated 64,050 new diagnoses and 50,550 deaths from pancreatic cancer occurred in the United States [1]. The prognosis of pancreatic cancer remains dismal, 5-year survival increased from 4% in 1997 to 12% in 2018 in pancreatic cancer patients of all stages [1].
13 gru 2023 · Pancreatic cancer remains among the malignancies with the worst outcomes. Survival has been improving, but at a slower rate than other cancers. Multimodal treatment, including chemotherapy, surgical resection, and radiotherapy, has been under investigation for many years.
22 sty 2024 · Survival analysis revealed 5-year overall survival rates of 74%, 69%, 57%, and 33% for stages 0, IA, IB, and IIA, respectively, with an overall improvement from 2004 to 2015. This increase was consistent among all age groups, genders, and races.
6 mar 2024 · Due to a lack of early detection and the limited efficacy of currently available treatments, pancreatic cancer 5-year survival rates are among the worst of any cancer at 11% [1, 4].
5 paź 2023 · Median disease-free survival, the primary end point, was 21.6 months in the mFOLFIRINOX group and 12.8 months in the gemcitabine group (HR 0.58, 95% CI 0.46–0.73; P < 0.001). Median overall ...
